Table 1.
Patient and tumor characteristics.
| N: 482 | N (%) |
|---|---|
| Age 50 Years (SD 12.6) | |
| Age (years) | |
| ≤40 | 101 (21%) |
| >40 | 381 (79%) |
| Menopausal status | |
| Pre | 247 (51.2%) |
| Post | 235 (48.8%) |
| BRCA carriers | |
| Yes | 43 (8.9%) |
| No | 439 (91.1%) |
| TNM anatomic | |
| IIA | 129 (26.8) |
| IIB | 199 (41.3) |
| IIIA | 80 (16.6) |
| IIIB | 63 (13.1) |
| IIIC | 11 (2.3) |
| TNM prognostic | |
| IB | 50 (10.4) |
| IIA | 140 (29) |
| IIB | 111 (23) |
| IIIA | 48 (10) |
| IIIB | 102 (21.2) |
| IIIC | 31 (6.4) |
| Pathology subtype | |
| Ductal | 459 (95.2) |
| Lobular | 14 (2.9) |
| Others | 9 (1.9) |
| Grade | |
| I | 20 (4.1) |
| II | 194 (40.2) |
| III | 254 (52.7) |
| Ki 67 | |
| ≤30 | 203 (42.1) |
| >30 | 279 (57.9) |
| Molecular surrogate subtype | |
| Luminal A-like | 46 (9.5) |
| Luminal B-like | 144 (29.9) |
| LuminalBHER2 | 91 (18.9) |
| HER2 | 78 (16.2) |
| TNBC | 123 (25.5) |
| TILs | |
| ≤20 | 295 (61.2) |
| >20 | 187 (38.8) |
Footnote: TILs: stromal tumor-infiltrating lymphocytes.